Cochrane at crossroads over drug company sponsorship

Ray Moynihan

doi:10.1136/bmj.327.7420.924

Cochrane at crossroads over drug company sponsorship

Ray Moynihan^*

^*Corresponding author for this work

Institute for Evidence-Based Healthcare

Research output: Contribution to journal › Comment/debate/opinion › Professional

9 Citations (Scopus)

Abstract

Can independent scientific evaluation be sponsored by vested interests? The Cochrane Collaboration's decision on this question at its annual colloquium next week could have a big effect on its future.

Original language	English
Pages (from-to)	924-926
Number of pages	3
Journal	British Medical Journal
Volume	327
Issue number	7420
DOIs	https://doi.org/10.1136/bmj.327.7420.924
Publication status	Published - 18 Oct 2003

Access to Document

10.1136/bmj.327.7420.924

Cite this

@article{79b99f351ef340168eebec788ec338da,

title = "Cochrane at crossroads over drug company sponsorship",

abstract = "Can independent scientific evaluation be sponsored by vested interests? The Cochrane Collaboration's decision on this question at its annual colloquium next week could have a big effect on its future.",

author = "Ray Moynihan",

year = "2003",

month = oct,

day = "18",

doi = "10.1136/bmj.327.7420.924",

language = "English",

volume = "327",

pages = "924--926",

journal = "British Medical Journal",

issn = "0959-8146",

publisher = "BMJ Publishing Group",

number = "7420",

}

TY - JOUR

T1 - Cochrane at crossroads over drug company sponsorship

AU - Moynihan, Ray

PY - 2003/10/18

Y1 - 2003/10/18

N2 - Can independent scientific evaluation be sponsored by vested interests? The Cochrane Collaboration's decision on this question at its annual colloquium next week could have a big effect on its future.

AB - Can independent scientific evaluation be sponsored by vested interests? The Cochrane Collaboration's decision on this question at its annual colloquium next week could have a big effect on its future.

UR - https://www.scopus.com/pages/publications/0142074283

U2 - 10.1136/bmj.327.7420.924

DO - 10.1136/bmj.327.7420.924

M3 - Comment/debate/opinion

C2 - 14563759

AN - SCOPUS:0142074283

SN - 0959-8146

VL - 327

SP - 924

EP - 926

JO - British Medical Journal

JF - British Medical Journal

IS - 7420

ER -

Cochrane at crossroads over drug company sponsorship

Abstract

Access to Document

Other files and links

Fingerprint

Cite this